April 17, 2016

Trellis presents "Antibodies Targeting LAG-3 , TIM-3, KIR Cloned from Healthy Human Donors” at AACR

September 22, 2014

Trellis Bioscience announces Michael Greenberg joining the company as VP of Business Development

July 11, 2014

Trellis Bioscience and ContraFect Announce Infectious Disease Antibody License

May 20, 2014

Trellis Bioscience to present results from work using its B-cell epitope identification and CellSpot antibody discovery technologies in the area of anti-drug antibodies at the May 20, 2014 AAPS National Biotechnology Conference

March 17, 2014

Trellis Bioscience and Amorphix to collaborate on anti-CD38 antibody treatment for cancer

September 16, 2013

Trellis Bioscience Presents at Upcoming 3rd Annual Mastering Immunogenicity Conference

April 23, 2013

Trellis Bioscience to Present at Upcoming Immunogenicity Conference

February 21, 2013

Trellis new CEO, Dr. Stefan Ryser, will be presenting a sketch of its oncology initiatives at the Texas Life Science Venture Forum hosted in Houston, Texas

February 14, 2013

Trellis launches its Antibody Repertoire Monitoring (ARM™) patient screening program

January 21, 2013

Trellis VP of R&D, Bill Usinger, was selected to present a talk describing the results of CellSpot™ deep screening of the immune repertoire of the OMT human transgenic rat at PEGS, held in Boston April 29-30, 2013

January 15, 2013

Trellis presents new data on antibodies targeting MRSA and Strep at the annual ASM conference to be held May 19-21, 2013 in Denver

January 13, 2013

Trellis announced today that Dr. Stefan Ryser has joined Trellis as its new CEO and Board Member

August 16, 2012

Trellis Bioscience Awarded SBIR Grant to Advance CMV Program

July 12, 2012

Trellis presents new data on Influenza at GTCbio conference in San Francisco, July 9-10, 2012

April 20, 2012

Trellis presents its Cellspot™ discovery platform at the Protein Engineering Summit held in Boston, April 30-May 3, 2012

December 29, 2011

Trellis presents new data on Influenza and CMV programs at IBC conference in San Diego, Dec 3-6, 2011.

August 31, 2011

Trellis Bioscience, LLC receives two separate SBIR grants from NIAID

May 31, 2011

Trellis Bioscience, LLC announced today issuance of US patent 7,939,344

December 1, 2009

Trellis Bioscience Grants MedImmune License for Its Anti-RSV Antibodies

October 26, 2007

Trellis Bioscience Discovers Anti-RSV Monoclonal Antibodies Isolated Directly from Human Blood Cells


About Us

Contact Us